109353 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines Interferons [IFN]
SOX9-INDUCED OLIGODENDROCYTE PROGENITOR CELLS
#2ISOLATION AND CULTURE CONDITIONS OF PERIPHERAL BLOOD-DERIVED STEM CELLS, AND INDUCTION OF DIFFERENTIATION INTO PROGENITOR CELLS BY USING SAME
#3NANOPARTICLES FOR DELIVERY OF IMMUNOREGULATORY MATERIALS TO T CELLS
#4METHOD FOR PRODUCING LOW-ANTIGENIC CELL
#5MATURATION OF DENDRITIC CELLS
#6MESENCHYMAL PROGENITOR CELLS FOR ENHANCING PARTIAL REPROGRAMMING OF TARGET CELLS
#7NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#8ANTICANCER COMPOSITION COMPRISING STEM CELL-DERIVED EXOSOMES AND PREPARATION METHOD THEREFOR
#9COMPOSITIONS AND METHODS FOR IMPROVED NK CELL THERAPIES
#10CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL
#11Method of Use for Benzofuran Compounds
#12CELL CULTURE MEDIUM
#13MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#14BIOLOGICAL AGE REVERSING PREPARATION AND METHOD FOR PREPARING SAME
#15PRE-CONDITIONED EXTRACELLULAR VESICLES AND METHODS OF PRODUCTION
#16CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#17SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER
#18INHIBITION OF GENOTOXIC STRESS TO IMPROVE T CELL ENGINEERING
#19CD83+, CD83+PD-L1+ MESENCHYMAL STEM CELLS AND PREPARATION METHODS AND USE THEREOF
#20REGULATORY T CELL STABILITY ASSAY
#21IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE
#22METHODS FOR IN VITRO MEMORY B CELL DIFFERENTIATION AND TRANSDUCTION WITH VSV-G PSEUDOTYPED VIRAL VECTORS
#23STEM CELL IMMUNOTHERAPY FOR COLITIS
#24COMPOSITIONS AND METHODS FOR ACTIVATING IMMUNE CELLS
#25GENETICALLY ENGINEERED T CELL FOR CELL THERAPY
#26CULTURE MEDIUM AND METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN MACROPHAGES AND USE THEREOF
#27STAGED CULTURE METHOD FOR IN-VITRO EXPANSION OF HUMAN CYTOKINE-INDUCED KILLER (CIK) AND USE THEREOF
#28METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA + T CELLS
#29CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#30PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#31PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#32Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#33BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#34CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#35PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#36COMPOSITION FOR PROMOTING PRODUCTION OF STEM CELL-DERIVED EXOSOMES AND INCREASING STEMNESS
#37METHODS FOR TREATING BLADDER CANCER
#38METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITION FOR TREATING CANCER
#39Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development
#40METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#41IMMUNE CELL POPULATIONS AND USES THEREOF
#42COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME
#43ENGINEERING OF GAMMA DELTA T CELLS AND COMPOSITIONS THEREOF
#44SHORT-TERM ACTIVATED DC1S AND METHODS FOR THEIR PRODUCTION AND USE
#45MonoMac-1 Cells Expressing CD16 and CD163
#46TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF
#47Composition and Method for Treating Diseases Thereof
#48CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS
#49COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#50MEANS AND METHODS OF PREVENTING OR REVERSING AGING
#51A METHOD FOR PRODUCING ANTIGEN-SPECIFIC T CELLS
#52ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THERAPEUTIC PROTEINS
#53HUMAN IPSC-DERIVED MACROPHAGES FOR LIVER REPAIR AND REGENERATION
#54METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS
#55METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
#56SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES
#57B-CELL BASED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS
#58METHOD FOR TREATING LUNG INJURY
#59UNIVERSAL DONOR CELLS AND RELATED METHODS
#60METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#61CGMP COMPLIANT PRODUCTION AND EXPANSION OF PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM AND PROGENITOR CELLS
#62METHOD FOR INHIBITING ADVENTITIOUS VIRAL INFECTION
#63STEM CELL PRIMING COMPOSITION AND PRIMED STEM CELL
#64NEW REGULATORY MACROPHAGES AND USES THEREOF
#65PREPARATION METHOD FOR TUMOR INFILTRATING LYMPHOCYTE AND USE THEREOF
#66METHOD FOR INDUCING ANTIGEN-SPECIFIC T CELL AND USE THEREOF IN TREATING CANCER OR VIRUS INFECTION
#67CELL COMPOSITIONS COMPRISING ANTIGEN-SPECIFIC T CELLS FOR ADOPTIVE THERAPY
#68STEM CELL-LIKE MEMORY T CELLS AND USES THEREOF
#69METHOD FOR PREPARING UNIVERSAL IMMUNE CELLS AND USE THEREOF
#70METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES
#71METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#72T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#73Methods of Preserving Mesenchymal Stem Cells
#74ONCOLYTIC VIRUS BOOSTS T CELL RESPONSE FOR EFFECTIVE TIL THERAPY
#75NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#76MRNA TRANSFECTION OF IMMUNE CELLS
#77METHOD OF PRODUCING MACROPHAGES
#78METHODS FOR ISOLATING GAMMA DELTA T CELLS
#79SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF
#80LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL STROMAL CELLS FOR CLINICAL USE
#81SIRPa Deficient Macrophages for Treating Cancer
#82AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USES
#83METHOD FOR THE PRODUCTION OF MATURE DENDRITIC CELLS IN VITRO USING A BACTERIAL LYSATE
#84ANTIGEN PRESENTING T CELLS, SENSITIZED, MANUFACTURED T CELLS AND METHODS OF TREATMENT USING THE SAME
#85METHOD OF EXPANDING AND GENERATING A POPULATION OF CYTOKINE-INDUCED KILLER CELLS FROM PERIPHERAL BLOOD
#86V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIES
#87Recombinant PD-L1 peptides and methods of use
#88PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#89Method for inhibiting growth of cancer cells using anti-cancer composition with mesenchymal stem cells conditioned medium
#90Decidual placental mesenchymal stem cell and the use of the cell for preparing pharmaceutical compositions for promoting angiogenesis
#91B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS
#92METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS
#93MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#94COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER
#95INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF
#96COMPOSITION FOR REINFORCING FUNCTION OF STEM CELL
#97PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#98PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#99CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY
#100PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#101PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#102PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#103Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#104METHODS FOR IN VITRO MEMORY B CELL DIFFERENTIATION AND TRANSDUCTION WITH VSV-G PSEUDOTYPED VIRAL VECTORS
#105PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#106REPROGRAMMING CELLS INTO HOMEOSTATIC MICROGLIA
#107PATIENT-MATCHED ORGANOID SYSTEMS FOR STUDYING CANCER
#108PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#109Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#110PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#111PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#112Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#113PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#114Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#115Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#116PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY
#117Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#118Cell populations having immunoregulatory activity, method for isolation and uses
#119Systems and methods for growth of intestinal cells in microfluidic devices
#120ANTIBODY PRODUCING MICROFLUIDIC DEVICES
#121CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#122METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#123HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#124COMPOSITIONS AND METHODS FOR DETECTING HIV LATENCY, TREATING HIV INFECTION, AND REVERSING HIV LATENCY
#125MULTIPLE ANTIGEN SPECIFIC CELL THERAPY METHODS
#126ENGINEERED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING THEREOF
#127BEAD-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T CELLS
#128SOX9-INDUCED OLIGODENDROCYTE PROGENITOR CELLS
#129COMPOSITION FOR PROMOTING PRODUCTION OF STEM CELL-DERIVED EXOSOMES AND INCREASING STEMNESS
#130CRYOPRESERVATION AND CELL CULTURE MEDIA
#131NOVEL EXOSOME PRODUCTION METHOD AND APPLICATION THEREOF
#132Methods of cancer treatment using tumor antigen-specific T cells
#133TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES
#134VIRUS SPECIFIC CYTOKINE-INDUCED KILLER CELLS
#135Material and method for storing, transferring and delivering mesenchymal stem cells which are immediately available and functional in the context of a myocardial infarction
#136CELL COMPOSITION COMPRISING LIVER PROGENITOR CELLS EXPRESSING HLA-E
#137Methods and reagents for modulating macrophage phenotype
#138T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy
#139METHODS AND APPARATUS FOR CONDITIONING CELL POPULATIONS FOR CELL THERAPIES
#140Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#141Constructs for chimeric antigen receptors
#142Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#143Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#144Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#145Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor
#146NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS
#147MEANS AND METHODS OF PREVENTING OR REVERSING AGING
#148METHODS FOR THE EXPANSION OF MESENCHYMAL STROMAL CELLS
#149Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#150Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#151Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#152Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#153Methods for the production of TCR gamma delta + t cells
#154Methods for the production of TCR gamma delta + T cells
#155Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#156Methods to Control Viral Infection in Mammalian Cells
#157Cellular Targeted Label Delivery System
#158Mycobacterial antigen compositions and methods of use
#159BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#160Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#161Methods for inducing an immune response by administering activated mesenchymal stem cells
#162Development of dual whole cell-based vaccine against pancreatic cancer
#163METHOD OF INDUCING DEDIFFERENTIATION OF SOMATIC CELLS WITH SMALL MOLECULES TO PREPARE REJUVENATED MESENCHYMAL STEM CELLS AND USES THEREOF
#164Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression
#165Methods of cancer treatment using tumor antigen-specific T cells
#166METHOD FOR THE IN VITRO DIFFERENTIATION AND MATURATION OF DENDRITIC CELLS FOR THERAPEUTIC USE
#167Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#168Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#169Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#170PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#171Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#172Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#173Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#174Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#175ANTI-LILRB ANTIBODIES AND USES THEREOF
#176Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#177N-Glycosylation
#178Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#179Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#180PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#181N-Glycosylation
#182N-Glycosylation
#183METHOD FOR PRODUCING HUMAN A1 ASTROCYTES, HUMAN A1 ASTROCYTES, AND METHOD FOR EVALUATING TEST SUBSTANCE
#184Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#185SINGLE B-CELL CULTIVATION METHOD
#186PRE-CONDITIONED EXTRACELLULAR VESICLES AND METHODS OF PRODUCTION
#187INTRACELLULAR NITRIC OXIDE AS A BIOMARKER FOR INCREASED SUSCEPTIBILITY SYSTEMIC INFLAMMATION
#188Method of producing natural killer cells and composition for treating cancer
#189MEDICAL USES OF EXOSOMES
#190Multiple antigen specific cell therapy methods
#191Method for activating T cells for cancer treatment
#192Methods and Compositions for Modulating TH-GM Cell Function
#193METHOD FOR PRODUCING LOW-ANTIGENIC CELL
#194COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS
#195MEDICINE FOR TISSUE REGENERATION, AND PREPARATION METHOD THEREFOR
#196Cell-based vehicles for potentiation of viral therapy
#197Method for producing myeloid-derived suppressor cells, myeloid-derived suppressor cells produced thereby, and methods thereof
#198Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#199Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#200NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#201Method for activating T cells for cancer treatment
#202Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#203MODIFIED T CELLS AND USES THEREOF
#204METHODS OF EXPANDING AND ASSESSING B CELLS AND USING EXPANDED B CELLS TO TREAT DISEASE
#205Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#206Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#207Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#208Combination immunotherapies for treatment of cancer
#209Methods of preparing hematopoietic progenitor cells in vitro
#210Methods and apparatus for conditioning cell populations for cell therapies
#211Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#212Allogeneic Dendritic Cells For Use In Cancer Treatment
#213INTERFERON PRIMED PLASMACYTOID DENDRITIC CELLS
#214CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#215Method of producing natural killer cells and composition for treating cancer
#216Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
#217Maturation of dendritic cells
#218Altered adherent stromal cells and methods of producing and using same
#219Indole regulation of antigen presenting cells
#220Short-term activated DC1s and methods for their production and use
#221Cellular targeted active ingredient delivery system
#222MonoMac-1 cells expressing CD16 and CD163
#223Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
#224STEM CELL MICROPARTICLES AND miRNA
#225Compositions and methods for in vitro cultivation and/or expansion of regulatory T cells
#226REGULATORY T CELL POPULATIONS
#227Cell-based vehicles for potentiation of viral therapy
#228NEW USE
#229Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#230Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#231Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#232Method For Sorting Highly Effective Stem Cells For Treating Immune Disorder
#233Method of producing natural killer cells and composition for treating cancer
#234CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#235NK-mediated immunotherapy and uses thereof
#236Combination immunotherapies for treatment of cancer
#237Methods and reagents for modulating macrophage phenotype
#238Method for cellular RNA expression
#239Universal donor cells and related methods
#240Induced dendritic cells and uses thereof
#241Methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors
#242Generation of HPV-specific T-cells
#243COMPOSITIONS AND METHODS FOR DIMINISHING AN IMMUNE RESPONSE
#244SUPPORT FOR CULTURING CELLS, METHOD OF PREPARING SUPPORT, AND METHOD OF CULTURING CELLS
#245Selection of Donors for Generation of Anti-Angiogenic Vaccine Compositions Including ValloVax
#246Systems and methods for growth of intestinal cells in microfluidic devices
#247Technique for Enhancing Stem Cell Regeneration Through Interaction of Vascular Endothelial Cell and Mesenchymal Stem Cell
#248METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#249CELL COMPOSITIONS COMPRISING ANTIGEN-SPECIFIC T CELLS FOR ADOPTIVE THERAPY
#250Methods of preserving mesenchymal stem cells
#251Development of dual whole cell-based vaccine against pancreatic cancer
#252Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#253Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#254Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#255Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#256BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#257Methods of producing activated mesenchymal stem cells
#258Systems and methods for growth of intestinal cells in microfluidic devices
#259T CELL RECEPTORS
#260Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
#261Induction medium and methods for stem cell culture and therapy
#262Generation of antigen-specific TCRs
#263Dendritic cell composition
#264Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#265Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#266Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#267Agents and compositions for eliciting an immune response
#268METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF
#269Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#270Method for enrichment and expansion of virus antigen-specific T cells
#271SINGLE B-CELL CULTIVATION METHOD
#272ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
#273Methods of expanding and assessing B cells and using expanded B cells to treat disease
#274Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#275Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
#276METHODS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
#277SYSTEM FOR IMMUNOTHERAPY TARGETING TUMOR PROPAGATION AND PROGRESSION
#278Generation of HPV-specific T-cells
#279Fusion molecule based on TAA variant
#280Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#281Methods and apparatus for conditioning cell populations for cell therapies
#282Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#283Method for controlling differentiation of embryonic stem cells into adipocytes or kidney precursor cells by regulating SIRT1 expression
#284Methods for the production of TCRγδ T cells
#285METHODS OF OBTAINING MONONUCLEAR BLOOD CELLS AND USES THEREOF
#286Compositions and methods for diminishing an immune response
#287Immunotherapy of Cancer by Induction of Immunologically-Mediated Selective Killing of Tumor Vasculature Using Modified Endothelial Cells and Progenitors Thereof
#288B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS
#289N-glycosylation
#290Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
#291INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
#292TRAIT INDUCTION METHOD OF UNDIFFERENTIATED CELLS
#293Co-differentiation of monocytes from allogeneic donors
#294Engineered Dendritic Cells and Uses for the Treatment of Cancer
#295CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#296CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES
#297IL-9 SECRETING CD8+ Tc9 CELLS AND METHOD OF TREATING CANCER
#298EX-VIVO INDUCED REGULATORY MESENCHYMAL STEM CELLS OR MYELOID-DERIVED SUPPRESSOR CELLS AS IMMUNE MODULATORS
#299Methods and compositions for modulating T-GM cell function
#300MANUFACTURING OF MULTI-DOSE INJECTION READY DENDRITIC CELL VACCINES, COMBINATION THERAPIES FOR BLOCKING HER2 AND HER3, AND ESTROGEN RECEPTOR POSITIVE HER2 BREAST RECEPTOR POSITIVE HER2 BREAST CANCER THERAPY